Araris Biotech AG Presents Data on Novel Antibody-Drug Conjugates at American Association for Cancer Research (AACR) Annual Meeting 2024
AU ZH, Switzerland, April 05, 2024 (GLOBE NEWSWIRE) -- Araris Biotech AG ("Araris" or "the Company"), a company pioneering a proprietary antibody-drug conjugate (ADC)- technology, today announced the company will
San Diego Convention Center United States San Diego Isabella Attinger Toller Veronica Eames Philipp Spycher
Source: benzinga.com